RRR

RADIOPHARM THERANOSTICS LTD.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪34.27 M‬USD
−0.0827USD
‪−31.96 M‬USD
‪199.47 K‬USD
‪1.92 B‬
Beta (1Y)
0.67

About RADIOPHARM THERANOSTICS LIMITED


CEO
Riccardo Canevari
Headquarters
Carlton
Founded
2021
ISIN
AU0000181851
FIGI
BBG014GJDFL0
Radiopharm Theranostics Ltd. operates as a pre-clinical and clinical research company. It focuses on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. The company is headquartered Carlton, Australia.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of RDPTF is 0.3000 USD — it has increased by ‪37.40 K‬% in the past 24 hours. Watch RADIOPHARM THERANOSTICS LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange RADIOPHARM THERANOSTICS LTD. stocks are traded under the ticker RDPTF.
RDPTF stock hasn't changed in a week, the month change is a ‪37.40 K‬% rise, over the last year RADIOPHARM THERANOSTICS LTD. has showed a 233.33% increase.
We've gathered analysts' opinions on RADIOPHARM THERANOSTICS LTD. future price: according to them, RDPTF price has a max estimate of 0.28 USD and a min estimate of 0.05 USD. Watch RDPTF chart and read a more detailed RADIOPHARM THERANOSTICS LTD. stock forecast: see what analysts think of RADIOPHARM THERANOSTICS LTD. and suggest that you do with its stocks.
RDPTF reached its all-time high on Oct 22, 2024 with the price of 0.3000 USD, and its all-time low was 0.0008 USD and was reached on Apr 1, 2024. View more price dynamics on RDPTF chart.
See other stocks reaching their highest and lowest prices.
RDPTF stock is 99.73% volatile and has beta coefficient of 0.67. Track RADIOPHARM THERANOSTICS LTD. stock price on the chart and check out the list of the most volatile stocks — is RADIOPHARM THERANOSTICS LTD. there?
Today RADIOPHARM THERANOSTICS LTD. has the market capitalization of ‪34.27 M‬, it has increased by 12.43% over the last week.
Yes, you can track RADIOPHARM THERANOSTICS LTD. financials in yearly and quarterly reports right on TradingView.
RADIOPHARM THERANOSTICS LTD. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
RDPTF net income for the last half-year is ‪−15.46 M‬ USD, while the previous report showed ‪−16.85 M‬ USD of net income which accounts for 8.28% change. Track more RADIOPHARM THERANOSTICS LTD. financial stats to get the full picture.
No, RDPTF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. RADIOPHARM THERANOSTICS LTD. EBITDA is ‪−23.56 M‬ USD, and current EBITDA margin is ‪−11.81 K‬%. See more stats in RADIOPHARM THERANOSTICS LTD. financial statements.
Like other stocks, RDPTF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RADIOPHARM THERANOSTICS LTD. stock right from TradingView charts — choose your broker and connect to your account.